Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Abbott’s Bioresorbable Stent Shows Durable Results In ABSORB Trial

This article was originally published in The Gray Sheet

Executive Summary

Latest clinical results for Abbott’s Absorb Bioresorbable Vascular Scaffold show the disappearing stent actually increases the space inside the stented vessel segment over time. The company’s efforts to launch a pivotal randomized trial of the device are hindered by FDA, according to the lead investigator.

You may also be interested in...

The Case For Disappearing Stents: More Positive Data For Abbott’s Absorb BVS

This year’s Transcatheter Cardiovascular Therapeutics meeting featured several presentations of favorable new data on Abbott’s Absorb bioresorbable vascular scaffold. The company is optimistic that it will be able to complete a PMA application to FDA for the disappearing stent by the end of 2015.

New Products In Brief

New cancer companion diagnostic approved. Biotronik’s Ilesto 7 ICD and CRT-D earns FDA approval. More new product announcements.

Research In Brief

Reva launches bioresorbable stent trial. Meta-analysis shows tests intended simply to reassure patients rarely do. Sorin launches trial of the SonR cardiac resynchronization system.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts